Semaglutide: FDA records on compounded and unapproved products

Has FDA taken action on compounded semaglutide?

Yes. As of Nov 15, 2026, FDA has issued 148 warning letters to 144 companies whose text names semaglutide, the latest dated Oct 30, 2026, and openFDA lists 52 recall reports naming it. FDA stated that tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list (statement dated Apr 1, 2026).

As of Nov 15, 2026, FDA’s drug shortage data lists semaglutide only with status “To Be Discontinued” (Semaglutide Tablet).

What FDA has stated, by date

FDA’s page does not date each paragraph; the date shown is the page’s “content current as of” date.

FDA drug shortage status

Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)Novo Nordisk, Inc.To Be DiscontinuedJun 4, 2026
Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)Novo Nordisk, Inc.To Be DiscontinuedJun 4, 2026
Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)Novo Nordisk, Inc.To Be DiscontinuedJun 4, 2026

Shortage history, by date

FDA’s words or recordSource
Mar 31, 2022Listed“Wegovy was approved by FDA in June 2021 (NDA 215256) and added to FDA’s drug shortage list on March 31, 2022.”FDA Declaratory Order, February 21, 2025: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy)
Aug 23, 2022Listed“Ozempic was approved by FDA in December 2017 (NDA 209637) and added to FDA’s drug shortage list on August 23, 2022.”FDA Declaratory Order, February 21, 2025: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy)
Feb 21, 2025Resolved“FDA has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Semaglutide injection products have been in shortage since 2022 due to increased demand.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Apr 22, 2025503A grace period end“For state-licensed pharmacists or physicians compounding under section 503A of the FD&C Act, 60 calendar days from the date of this order, until April 22, 2025”FDA Declaratory Order, February 21, 2025: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy)
Apr 24, 2025Litigation“On April 24, 2025, the district court denied the plaintiffs’ preliminary injunction motion in Outsourcing Facilities Association v. FDA, 4:25-cv-00174 (N.D. Tex.) regarding compounded semaglutide.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
May 22, 2025503B grace period end“For outsourcing facilities under section 503B of the FD&C Act, 90 calendar days from the date of this order, until May 22, 2025.”FDA Declaratory Order, February 21, 2025: Resolution of Shortages of Semaglutide Injection Products (Ozempic and Wegovy)
Apr 1, 2026Status statement“Tirzepatide and semaglutide do not currently appear on the 503B bulks list or on FDA’s drug shortage list.”FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
Jun 4, 2026To Be DiscontinuedFDA’s shortage data posts Semaglutide Tablet (Rybelsus) with status “To Be Discontinued,” first posted Jun 4, 2026: 3 presentations.FDA drug shortage data, via openFDA drug shortages endpoint

All GLP-1 drugs on one timeline: shortage history.

FDA adverse event reports (FAERS) listing semaglutide

openFDA’s copy of FDA’s adverse event database holds 111,278 reports that list semaglutide, received from Jan 23, 2013 through Sep 30, 2026. 56,072 (50%) are marked serious by the reporter, including 1,741 that list death as an outcome. 217 reports name a compounded or combination semaglutide product in the product fields. These are unverified reports and do not show that the drug caused any event.

FAERS reports are sent to FDA by drug makers, health professionals and the public. FDA does not verify them, a report does not show that the drug caused the event, and the same event can be reported more than once. Counts reflect how often events were reported, not how often they happen or how risky a drug is. Nothing here is medical advice. Report an error or add a company response.

Reports by year FDA received them

20132
20144
20158
201620
201721
20181,168
20191,833
20203,960
20215,521
20228,078
202311,886
202419,166
202527,521
202632,090

Reaction terms listed most often

Nausea15,62414.0%
Vomiting10,4169.4%
Off label use9,5668.6%
Diarrhoea8,8047.9%
Constipation6,4815.8%
Decreased appetite6,1055.5%
Weight decreased5,5185.0%
Fatigue4,7984.3%
Impaired gastric emptying4,5494.1%
Headache4,4794.0%

A report can list several reaction terms. Terms such as “Off label use” or “Incorrect dose administered” describe how the drug was used, not a bodily reaction.

Reports naming a compounded or combination semaglutide product

In openFDA’s public copy of FDA’s adverse event data, checked Nov 15, 2026, 217 reports of the 111,278 listing semaglutide have product text that identifies a compounded or combination product: 210 list semaglutide combined with a vitamin or amino acid such as cyanocobalamin (vitamin B12), and 8 use the word “compounded” or “compound” in the product name or dosage text (1 meets both tests). The public data has no compounded flag and no narrative, so this is a floor, not a full count, and the reports are unverified. More on the compounded semaglutide reports page.

A report is counted as naming a compounded product only when one drug entry in it names the drug and that same entry either uses the word “compounded”, “compounding” or “compound” in its product name or dosage text, or lists the drug together with cyanocobalamin, methylcobalamin, pyridoxine, glycine, levocarnitine, carnitine, niacinamide or vitamin B12 or B6 in one product name, a combination no FDA-approved product of these drugs contains. openFDA’s public data has no field that marks a product as compounded and leaves out the report narrative, so this finds only reports whose product text shows it. FDA’s own counts for compounded semaglutide and tirzepatide, from its full internal data, are higher.

Report
Sep 30, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27332952
Sep 28, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27319074
Sep 26, 2026LEVOCARNITINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27317300
Sep 24, 2026PYRIDOXINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27310872
Sep 24, 2026METHYLCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27311146
Sep 17, 2026LEVOCARNITINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27278064
Sep 16, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27272422
Sep 16, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27272458
Sep 15, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27262024
Sep 11, 2026GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27248253
Sep 11, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27248523
Aug 31, 2026PYRIDOXINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27195587
Aug 31, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27196661
Aug 28, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27181342
Aug 28, 2026PYRIDOXINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27184633
Aug 28, 2026SEMAGLUTIDEProduct text says compoundedSuspectNoopenFDA 27184699
Aug 28, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27184825
Aug 28, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27184878
Aug 28, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27189965
Aug 27, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27183056
Aug 27, 2026CYANOCOBALAMIN\GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27183058
Aug 26, 2026GLYCINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27178113
Aug 24, 2026CYANOCOBALAMIN\NADIDE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectYesopenFDA 27161750
Aug 24, 2026PYRIDOXINE\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27161754
Aug 24, 2026CYANOCOBALAMIN\SEMAGLUTIDECombined with a vitamin or amino acidSuspectNoopenFDA 27166227

The 25 most recent are shown; all 217 are on the adverse event reports page.

Active ingredient (API) imports: FDA import alert and refusal records

FDA’s Import Alert 66-80 Green List (published Oct 9, 2026) has 10 entries naming semaglutide, in China (7), Belgium (1), Denmark (1) and Portugal (1); FDA redacts the firm names. FDA’s import refusal records list 501 refused shipment lines whose product code names semaglutide, from Jun 16, 2023 to Oct 30, 2026, most often from Canada (208), Denmark (149) and United States (26); 11 carry an API or powder product code listed on the alert.

Import Alert 66-80 Green List entries naming semaglutide

Product codes and drugs listed
1Redacted by FDABELGIUM61P[][]72 Semaglutide (Anti-Diabetic)
61P[][]75 Exenatide (Anti-Diabetic)
4Redacted by FDACHINA56F[][]99 Peptide N.E.C. (Antibiotics)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]99 Anti-Diabetic N.E.C. (Anti-Diabetic)
5Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
7Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
8Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
10Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
12Redacted by FDACHINA61P[][]72 Semaglutide (Anti-Diabetic)
61P[][]74 Tirzepatide (Anti-Diabetic)
13Redacted by FDACHINA61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)

61P[][]74 Tirzepatide (Anti-Diabetic)
15Redacted by FDADENMARK61P[][]76 Liraglutide (Anti-Diabetic)
61P[][]72 Semaglutide (Anti-Diabetic)
20Redacted by FDAPORTUGAL61P[][]72 Semaglutide (Anti-Diabetic)
61P[][]77 Orforglipron SDD (Anti-Diabetic)

Refused semaglutide lines by country and form

Canada208
Denmark149
United States26
China19
Colombia17
United Kingdom15
India14
Mexico11
Brazil9
Bangladesh5
Germany4
Singapore4
France3
Hong Kong2
Israel2
Japan2
Nigeria2
Albania1
Bulgaria1
Egypt1
Greece1
Honduras1
Indonesia1
Italy1
Philippines1
Turkey1
Code not listed on Import Alert 66-80490
Active Pharm Ingred/Chems for Rx Compounding8
NonSterile Powder2
Active Pharm Ingred/Chems for Further Manuf1

Most recent refused semaglutide lines

Shipment ID
Oct 30, 2026NOVO NORDISKCanada61PCK72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-8781355-7/10003/1
Oct 14, 2026Name not shownFrance61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80SCS-5123290-6/10003/1
Oct 7, 2026XU LIHUA JINGFANG Trading Co. LTDChina61PIR72 SEMAGLUTIDE (ANTI-DIABETIC)NonSterile PowderXXX-0763336-3/1/4
Sep 18, 2026Name not shownUnited States61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9731409-8/20001/1
Sep 9, 2026Name not shownFrance61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80SCS-5013553-0/10003/1
Aug 31, 2026NOVO NORDISKCanada61PCL72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80799-1109746-0/10003/1
Aug 18, 2026Novo Nordisk A/SDenmark61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-809H5-0019713-6/10002/1
Aug 14, 2026Novo Nordisk A/SDenmark61PCK72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0899165-4/10002/1
Aug 13, 2026Novo Nordisk A/SDenmark61PCK72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-2262166-8/10002/1
Aug 12, 2026Novo Nordisk A/SDenmark61PCP72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-809H5-0019708-6/10002/1
Jul 30, 2026Novo Nordisk A/SDenmark61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-3429534-5/10002/1
Jul 24, 2026Novo Nordisk A/SDenmark61PCL72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-3078600-8/10002/1
Jul 21, 2026Novo Nordisk A/SDenmark61PCE72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0505963-8/10002/1
Jul 13, 2026ASIAN SUITS ONLINE LIMITEDUnited Kingdom61PIK72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80ITC-0045415-9/10002/1
Jul 10, 2026NOVO NORDISKCanada61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0725103-5/10002/1
Jun 30, 2026Hybio Pharmaceutical Co., Ltd.China61PBY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-808NP-0146038-9/10002/1
Jun 29, 2026NOVO NORDISK INDIA PRIVATE LIMITIndia61PCY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-9338523-3/30003/1
Jun 26, 2026Name not shownIndia61PBY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-80AEK-0581038-6/10002/1
Jun 22, 2026Novo Nordisk Inc.United States61PCL72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-5519360-0/10001/1
Jun 12, 2026Pharmhub PharmacyUnited Kingdom61PDY72 SEMAGLUTIDE (ANTI-DIABETIC)Code not listed on Import Alert 66-801FX-0303880-9/10002/1

The 20 most recent of 501 are shown, with charges, on the GLP-1 import records page and in the CSV download.

All firms and countries: Firms on GLP-1 import records. Answer page: Where does compounded semaglutide API come from?

FDA NDC Directory listings

FDA’s NDC Directory files read Nov 15, 2026 carry 188 listings naming semaglutide: BULK INGREDIENT (56); OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) (38); BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING (35); NDA (32); DRUG FOR FURTHER PROCESSING (27). Outsourcing facility listings: Which outsourcing facilities list compounded semaglutide or tirzepatide with FDA? Every listing: GLP-1 listings in FDA’s NDC Directory. FDA says an NDC “does not in any way denote FDA approval of the product.”

Medicare and Medicaid spending on semaglutide

Medicare Part D spent $15.16 billion on semaglutide brands in 2024 (Ozempic $12.97 billion, Rybelsus $1.89 billion, Wegovy $301.3 million), before manufacturer rebates, according to CMS. Pharmacies were reimbursed at least $6.61 billion for semaglutide products paid through Medicaid nationwide in 2025, across at least 5,892,727 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 21 rows of 132, so these figures are floors.

Medicare Part D, by brand and year

OzempicSemaglutide$1,455,812,267$2,621,694,348$4,628,160,643$9,194,048,435$12,970,296,347
RybelsusSemaglutide$73,444,409$454,563,823$974,894,470$1,665,906,943$1,890,082,026
WegovySemaglutideNo dataNo dataNo data$199,774$301,283,291

Medicaid, nationwide, by year

2020at least $283,898,491
2021at least $554,820,690
2022at least $1,149,248,802
2023at least $2,911,348,586
2024at least $5,107,538,873
2025at least $6,613,338,249
2026 (Q1)at least $1,251,443,577

Figures are before manufacturer rebates, as CMS reports them. Every GLP-1 drug, CMS’s caveats and each state: Medicare and Medicaid spending on GLP-1 drugs.

FDA warning letters naming semaglutide

Later letters FDA listsLetter
Oct 30, 2026RonanRx, Inc. dba RonanRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 24, 2026Cheap Medicine Shop/www.cheapmedicineshop.comUnapproved New Drugs/Misbranded (Internet Pharmacy)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 23, 2026Online Generic Medicine/www.onlinegenericmedicine.comUnapproved New Drug/Misbranded (Internet Pharmacy)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 18, 2026Empower Clinic Services, LLC dba Empower PharmacyCGMP/Finished Pharmaceuticals/Adulterated/Unapproved New DrugSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026TXP Innovations LLC dba Tex PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Royal Peptides LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026NuScience Peptides LLCUnapproved New Drugs/MisbrandedSemaglutide, Retatrutide, Survodutide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Peptide Partners LLCUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 24, 2026Peak Performance PeptidesUnapproved New Drugs/MisbrandedSemaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Maximus Health, Inc. dba MaximusFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Trinity HealthCare Supply, LLC dba altRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Glow Medispa, LLC dba Mint MedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Ezra Holdco LLC dba EzraFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Public Health Solution LLC dba DrMedHealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026D&H Medical ServicesFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Amie Health, Inc. dba AmieFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Altru Telehealth, LLC dba Altru TelehealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Eden Health International Inc. dba EdenFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026NativeMed LLC dba NativeMedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026FitRX, LLC dba AM RXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Momentum Health 360 dba Momentum HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, Tirzepatide, LiraglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Medica Weight LossFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Clover Meds LLC dba Clover MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nexlife Inc. dba NexlifeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Roen Health, Inc. dba RoenRxFalse & Misleading Claims/Misbranded (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Joi and Blokes dba Joi + BlokesFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026VivioMD Group LLC dba VivioMDFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Thrivelab Co. dba ThrivelabFalse & Misleading Claims/Misbranded (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nexus Health Solutions LLC dba Harper MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Nova Vascular LLC dba NOVARXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026Ready MedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026OrderlyMeds LLC dba OrderlyMedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026HydraMed IV LLC dba HydraMedFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 8, 2026FITISHFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
May 1, 2026Harbin Jixianglong Biotech Co., Ltd.CGMP/API/Adulterated and Misbranded DrugsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 14, 2026New Life Pharma LLCCGMP/Adulterated and Unapproved New Drug/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 7, 2026ProRx LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Prime SciencesUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Mar 31, 2026Mile High Compounds LLCUnapproved New Drugs Sold Over the InternetSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Premium Health Management Inc. dba Premium HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Bliv Wellness LLC dba BlivFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026BluefitMDFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Aspen Aesthetics dba Fifty 410False & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026FitRX, LLC dba FitRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Genesis Health International Inc. dba GenesisFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Lean Rx, Inc. dba SkinnyRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Kare Solutions, LLC dba ZappyFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, Tirzepatide, LiraglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Strut Health, LLC dba StrutFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Refills Health, LLC dba Refills HealthFalse & Misleading Claims/Misbranded (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Weightless Medical LLC dba WeightCareFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Viv Health, Inc. dba VIV RXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Peaks Curative, LLC dba PeaksFalse & Misleading Claims/Misbranded (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026PharmaZeeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Good Girl LLC dba GoodGirlRXFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Ivim Services LLC dba IvimFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Join JosieFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Kin MedsFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Levity Inc. dba LevityFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, LiraglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026MaxLife Technologies Inc. dba MaxlifeFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Better Health Labs, Inc. dba MeasuredFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026MEDVi, LLC dba MEDViFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Newman Clinic, PLLC dba Newman ClinicFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026NewSelf Limited dba NewSelfFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 202624HrDoc, Inc. dba 24HrDocFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Alan Health Technologies Inc. dba AlanFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Dripgym Mobile Parent, LLC dba Amp HealthFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 20, 2026Belle Health LLC dba BelleFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jan 20, 2026GenoGenix LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Jan 16, 2026Boothwyn Pharmacy, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 1, 2025Apothecary Pharma, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Oct 10, 2025PQ Pharmacy, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 11, 2025Chengdu Brilliant Biopharmaceutical Co., Ltd.CGMP/Finished Pharmaceuticals/AdulteratedSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 10, 2025motionpharmacy.comUnapproved New Drug/MisbrandedSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Expert AestheticsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Healthy Living ClinicUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Hims & Hers Health, Inc. dba HersUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Amazing MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GenLabMedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025FitRX, LLC dba ZealthyUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Get.Fit.Medical, LLC dba Get.Fit.MedicalUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025FWD Care, Inc. dba FWDUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025iVisitDoc, Inc. dba iVisitDocUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lean Dreams LLC dba LeanDreamsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025ybycmedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Try NovaUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025The HCG InstituteUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Vitals RXUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Las Villas Health Care LLC dba Villas HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Tuyo Health, Inc. dba Tuyo HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lovely Meds, Inc. dba Lovely MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Lyfe RxUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025inspire.clinicUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Bioverse, Inc. dba BioverseUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025SimpleRxUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Elevate Your Wellness LLC, dba ElevatedUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Cosmo Medical Spa dba Cosmo Med SpaUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025EvoLife WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Nuvo Life Health Inc. dba Nuvo Life HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025SemaBioUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025directmeds.com, Inc. dba DirectMedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Hims & Hers Health, Inc. dba HimsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025MedClub by Dr. JennUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Mane & Steel, LLC. dba Mane & SteelUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025LumimedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025GLP-1 SolutionUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025ASN-LABSUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Body Good StudioUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Canada Med StopUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025All American WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Intimate RoseUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Invigorate Med SpaUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Dr. Gater’s Weight Loss & WellnessUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Remedy MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025EA WORKS Limited Liability Company dba Trust LabsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Fancy Meds, LLC dba Fancy MedsUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Matthew Stern, CEO MyStart Health LLC.Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Elite Health CenterUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025CurexUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Healthon Inc. dba HealthonUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025JulyMDUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025SlendidUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Sprout Health Partners LLC dba Sprout HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Master Pharmaceuticals GroupUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025TRYM Health, Inc. dba TRYM HealthUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025HealBerryUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Reset IV, LLC dba Reset IVUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 9, 2025Healthy MaleUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jul 29, 2025cheaptrustedpharmacy.comNotice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 12, 2025www.buynetmeds.comUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
May 5, 2025www.peacefulmeds.comUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 23, 2025www.24hreup.bizNotice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 8, 2025Tailstorm Health Inc. dba Medivant HealthCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideClose-out letter, Apr 14, 2026fda.gov
Mar 4, 2025ProRx, LLCCompounding Pharmacy/Adulterated Drug ProductsSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 26, 2025USApeptide.comUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Jan 13, 2025www.weightcrunchshop.comUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Prime Vitality, Inc. dba Prime PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024SwisschemsUnapproved New Drugs/MisbrandedSemaglutide, RetatrutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Xcel Research LLCUnapproved New Drugs/MisbrandedSemaglutide, Retatrutide, Cagrilintide, Survodutide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Dec 10, 2024Summit Research PeptidesUnapproved New Drugs/MisbrandedSemaglutide, Tirzepatide, Retatrutide, Cagrilintide, MazdutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 12, 2024Nomida.bizUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Aug 20, 2024AnuMed International, LLCFinished Pharmaceutical/Unapproved New Drug/Adulterated/MisbrandedSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Jun 24, 2024Ozempen.comUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Apr 24, 2024www.dashpct.comUnlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024US Chem LabsCGMP/Finished Pharmaceuticals/AdulteratedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Feb 7, 2024Synthetix Inc. DBA Helix Chemical SupplyUnapproved New Drugs/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov
Oct 2, 2023www.semaspace.comFinished Pharmaceuticals/Unapproved New Drug/MisbrandedSemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Oct 2, 2023www.gorillahealing.comFinished Pharmaceuticals/Unapproved New Drug/MisbrandedSemaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

Recalls naming semaglutide

Record
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0026-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0019-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0018-2027
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, S...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0755-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0747-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO ...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0748-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, S...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0753-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO ...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0749-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0752-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0757-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 1...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0756-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0751-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 652...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0750-2026
Jul 29, 2026Apollo Care, LLCSEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 10...Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialClass IIOngoingD-0754-2026
Mar 6, 2026PAYLESS COMPOUNDERS, LLCSemaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, ORLack of Assurance of SterilityClass IIOngoingD-0471-2026
Feb 26, 2026New Life Pharma LLCSemaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-06Lack of Assurance of SterilityClass IIOngoingD-0393-2026
Feb 26, 2026New Life Pharma LLCSemaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-001-07.Lack of Assurance of SterilityClass IIOngoingD-0392-2026
Feb 13, 2026Harbin Jixianglong Biotech Co., Ltd.Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; ...CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation be...Class IIOngoingD-0380-2026
Feb 13, 2026Harbin Jixianglong Biotech Co., Ltd.Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d...CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation be...Class IIOngoingD-0379-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 841...Lack of Assurance of SterilityClass IIOngoingD-0115-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84...Lack of Assurance of SterilityClass IIOngoingD-0116-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 8413...Lack of Assurance of SterilityClass IIOngoingD-0118-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84...Lack of Assurance of SterilityClass IIOngoingD-0117-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139...Lack of Assurance of SterilityClass IIOngoingD-0114-2026
Oct 15, 2025ProRx LLCSemaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 8413...Lack of Assurance of SterilityClass IIOngoingD-0119-2026
Jul 30, 2025GenoGenix LLCSemaglutide for Injection, a) 20 mg b) 20 mg/mL, 10 mL Multi-Dose Vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as m...Lack of Assurance of SterilityClass IIOngoingD-0091-2026
Jul 30, 2025GenoGenix LLCSemaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.Lack of Assurance of SterilityClass IIOngoingD-0083-2026
Jul 18, 2025AEQUITA PHARMACYSemaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, D...Lack of Processing Controls.Class IIOngoingD-0563-2025
Jul 18, 2025AEQUITA PHARMACYSemaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dos...Lack of Processing Controls.Class IIOngoingD-0564-2025
Jul 18, 2025AEQUITA PHARMACYSemaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate,...Lack of Processing Controls.Class IIOngoingD-0562-2025
Jul 18, 2025AEQUITA PHARMACYSemaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do n...Lack of Processing Controls.Class IIOngoingD-0553-2025
Jul 18, 2025AEQUITA PHARMACYSemaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate...Lack of Processing Controls.Class IIOngoingD-0561-2025
Jul 18, 2025AEQUITA PHARMACYSemaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate,...Lack of Processing Controls.Class IIOngoingD-0565-2025
Jul 9, 2025Boothwyn Pharmacy LLCSemaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn PharmacySubpotent DrugClass IIOngoingD-0608-2025
Jul 9, 2025Boothwyn Pharmacy LLCSemaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn PharmacySubpotent DrugClass IIOngoingD-0606-2025
Jul 9, 2025Boothwyn Pharmacy LLCSemaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn PharmacySubpotent DrugClass IIOngoingD-0609-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0480-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0479-2025
May 21, 2025Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112Lack of Assurance of SterilityClass IIOngoingD-0481-2025
Aug 22, 2024ProRx LLCSemaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01Lack of Assurance of SterilityClass IIOngoingD-0650-2024
Aug 22, 2024ProRx LLCSemaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02Lack of Assurance of SterilityClass IIOngoingD-0654-2024
Aug 22, 2024ProRx LLCSEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01Lack of Assurance of SterilityClass IIOngoingD-0652-2024
Aug 22, 2024ProRx LLCSEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04Lack of Assurance of SterilityClass IIOngoingD-0653-2024
Aug 15, 2023TMC Acquisitions LLC dba Tailor Made CompoundingSemaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.Lack of Assurance of SterilityClass IITerminatedD-1105-2023
Apr 13, 2023Pharmacy Plus, Inc. dba Vital Care CompounderC-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402Lack of assurance of sterility.Class IIOngoingD-0538-2023
Dec 22, 2022Pharmacy InnovationsSEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 4MG/ML (0.5ML ...Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Class IITerminatedD-0236-2023
Oct 7, 2022Pharmacy Plus, Inc. dba Vital Care CompounderSEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility ...Class IIOngoingD-0053-2023
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 24/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1521-2022
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1519-2022
Aug 26, 2022Carolina InfusionSemaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.Lack of Assurance of SterilityClass IICompletedD-1520-2022
Mar 7, 2022TMC Acquisition LLC dba Tailor Made CompoundingSemaglutide/Cyanocobalamin 5mg/0.2mg/ml, 2ml-vial, Refrigerate, Tailor Made CompoundingLack of Assurance of SterilityClass IIOngoingD-1225-2022
Mar 7, 2022TMC Acquisition LLC dba Tailor Made CompoundingSemaglutide/Cyanocobalamin 2mg/0.4mg/ml, 1mL-vial, Refrigerate, Tailor Made CompoundingLack of Assurance of SterilityClass IIOngoingD-1224-2022

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.